Summary:
Northern California Research is conducting a study for Benign Prostatic Hyperplasia (BPH). The purpose of the study to see whether or not the study medication will reduce the size of the prostate in men with enlarged prostates with urinary tract symptoms, and to see its effects on a blood marker associated with prostate size, prostate specific antigen (PSA). The study is approximately 6 months long and there are 9 office visits to our site.
Qualified Participants Must:
• Be 45 years of age or older
•
Have a PSA between 4.0 and 10.0 ng/mL
•
Be willing to discontinue current BPH medication for the duration of the study
•
Not have had prostate cancer
Qualified Participants May Receive:
All trial-related visits, tests, and medications will be provided to you at no cost. In addition, reimbursement for trial-related time and travel may be provided